After performing a new in-depth analysis of its major U.S. trial, pharmaceutical corporation AstraZeneca has declared its COVID-19 vaccine to be 76% effective at preventing serious cases of the illness. This figure is slightly lower than the rate that was mentioned earlier this week in a report that relied...
An array of European stock markets opened higher on Tuesday morning, despite the ongoing challenges faced by European Union member states in terms of their vaccine rollout campaigns. Following reports of blood clotting, several European nations including France, Germany, Italy, and Spain have suspended their rollout of the AstraZeneca...
Pfizer Inc has approached the Indian government with an offer to produce doses of its COVID-19 vaccine locally. This is a rapid shift from the pharmaceutical company's initial stance, which was to import doses to India from the United States and European manufacturing facilities.
The proposal to produce vaccines locally...
The United States government is set to enter into a contract with pharmaceutical manufacturer Johnson & Johnson to purchase 100 million doses of the company's single-jab coronavirus vaccine, set to be administered during the second half of 2021.
According to CNBC, the U.S. President is expected to officially announce the...
Australian health authorities revealed on Wednesday that the country is expected to complete its coronavirus vaccination drive by the end of October. With 100,000 vaccine doses having been administered since the start of the campaign, the Australian nation has expressed little concern over its relatively slow vaccination program, particularly...
A top South African health official revealed on Friday that the South African government is currently in talks with the African Union (AU) over the purchase of COVID-19 vaccines for 10 million people.
Before deciding to halt the rollout of its AstraZeneca shots, the South African government had previously...
Pharmaceutical manufacturer AstraZeneca has sold its entire 7.7% stake in U.S. biotech firm Moderna, raking in a revenue of more than $1 billion as a result. The English-Swedish company is looking to use the income from the sale to expand its own internal operations, namely by developing its own...
Multinational science and technology company Merck KGgA announced on Monday that it has closed a deal with Swiss biotech company Debiopharm to develop and market its Xevinapant drug for head and neck cancer. The deal is estimated to be worth 900 million euros ($1.08 billion).
The terms of the deal...
After 33 years of operational difficulties, American vaccine development company Novavax has finally received approval for its COVID-19 vaccine shot. According to testing results, the Novavax vaccine has efficacy rates that are of a similar level to the vaccines developed by Pfizer and BioNTech as well as Moderna.
As the...
Johnson & Johnson's single-dose coronavirus shot recently received emergency use approval from the U.S. Food and Drug Administration on Saturday evening, making it the third COVID vaccine available for use in the United States.
Following the conclusion of early-phase clinical trials, the pharmaceutical giant submitted data regarding its results to...